New, cross-sector collaboration aims to discover clinical biomarker for pancreatic cancer

| April 9, 2015 | 0 Comments

The search to discover and validate the first-ever clinical biomarker to diagnose and treat pancreatic cancer is at the foundation of a new, cross-sector collaboration. Berg, a biopharmaceutical company committed to uncovering health solutions through a data-driven, biological research approach; the Cancer Center at Beth Israel Deaconess Medical Center, a Harvard Medical School teaching hospital …

More:
New, cross-sector collaboration aims to discover clinical biomarker for pancreatic cancer

Tags: , , , , , , ,

Category: Recent News

About the Author ()

Leave a Reply